ClinicalTrials.Veeva

Menu

Validation of a Non-invasive Hemodynamic Monitor (NexFin) in Pregnant Women

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Completed

Conditions

Hemodynamic Changes in Pregnancy

Study type

Observational

Funder types

Other

Identifiers

NCT01861132
NexValid13

Details and patient eligibility

About

Blood pressure and cardiac output can be measured invasively in pregnant women. Non-invasive monitoring devices are desirable, but until now, no equipment has proven validity. This study aims at validating the non-invasive monitoring device NexFin (second generation Finometer) in pregnant women.

Full description

Validation will be a direct beat-to-beat comparison of data from NexFin and the invasive measurements of blood pressure and calibrated cardiac output as an integrated part of LiDCO Plus. Both comparison of absolute values and the two different devices trending abilities will be analyzed.

Enrollment

20 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Healthy singleton pregnancies at term scheduled for cesarean delivery

Exclusion criteria

  • Twins, or multiple gestation, pre-eclampsia, gestational hypertension
  • Reynaud phenomenon

Trial design

20 participants in 1 patient group

Healthy pregnant women
Description:
Healthy pregnant women for C-section under spinal anesthesia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems